Biotest
Corina Heinz is an experienced professional in the field of clinical research and development, currently serving as Manager of Clinical Strategy and Development at Biotest AG since September 2017 and as Project Manager of GxP Analytics Development at GANYMED Pharmaceuticals GmbH since April 2017. With a background that includes roles at GANYMED Pharmaceuticals AG and the Chemotherapeutisches Forschungszentrum "Georg-Speyer-Haus," Corina has a proven track record in developing and validating potency assays, conducting preclinical research, and managing complex projects involving teams of scientists. Corina's earlier work encompasses postdoctoral research and a PhD in Molecular Biology from Goethe-Universität Frankfurt a. Main, reflecting expertise in molecular characterization and gene regulation.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.